Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
T-Mobile US
TMUS
|
+$530M |
| 2 |
AbbVie
ABBV
|
+$429M |
| 3 |
Boston Scientific
BSX
|
+$292M |
| 4 |
Snap
SNAP
|
+$241M |
| 5 |
Royalty Pharma
RPRX
|
+$223M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boeing
BA
|
+$327M |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$295M |
| 3 |
AMTD
TD Ameritrade Holding Corp
AMTD
|
+$294M |
| 4 |
Sysco
SYY
|
+$209M |
| 5 |
Shopify
SHOP
|
+$176M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 30.65% |
| 2 | Healthcare | 19.7% |
| 3 | Consumer Discretionary | 10.81% |
| 4 | Financials | 9.9% |
| 5 | Communication Services | 8.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1026
TD Synnex
SNX
$19.9B
| $2.01M | ﹤0.01% |
33,548
-32,864
| -49% | -$1.54M |
|
1027
Hawaiian Electric Industries
HE
$2.26B
| $2M | ﹤0.01% |
55,474
-7,443
| -12% | -$288K |
|
1028
Southwest Airlines
LUV
$21.7B
| $1.99M | ﹤0.01% |
58,174
+26,621
| +84% | +$846K |
|
1029
Lincoln National
LNC
$7.92B
| $1.98M | ﹤0.01% |
53,853
-1,400
| -3% | -$49.3K |
|
1030
Western Alliance Bancorporation
WAL
$8.81B
| $1.97M | ﹤0.01% |
52,088
-47,129
| -48% | -$1.65M |
|
|
CXO
1031
DELISTED
CONCHO RESOURCES INC.
CXO
| $1.97M | ﹤0.01% |
38,264
+1,592
| +4% | +$88K |
|
1032
Vanguard Small-Cap ETF
VB
$78.9B
| $1.96M | ﹤0.01% |
13,448
-35,910
| -73% | -$4.82M |
|
1033
Penumbra
PEN
$12.6B
| $1.95M | ﹤0.01% |
10,915
-519
| -5% | -$90.1K |
|
|
KALV
1034
DELISTED
KalVista Pharmaceuticals
KALV
| $1.94M | ﹤0.01% |
160,776
+8,469
| +6% | +$90.1K |
|
1035
Zscaler
ZS
$24.9B
| $1.94M | ﹤0.01% |
+17,719
| New | +$1.47M |
|
1036
Vanguard FTSE All-World ex-US ETF
VEU
$64.9B
| $1.93M | ﹤0.01% |
40,424
-13,121
| -25% | -$588K |
|
1037
OneMain Financial
OMF
$7.27B
| $1.91M | ﹤0.01% |
77,919
-4,197
| -5% | -$95.6K |
|
1038
FormFactor
FORM
$6.49B
| $1.91M | ﹤0.01% |
+65,134
| New | +$1.61M |
|
|
BEAT
1039
DELISTED
BioTelemetry, Inc.
BEAT
| $1.86M | ﹤0.01% |
41,060
+20,232
| +97% | +$907K |
|
1040
United Therapeutics
UTHR
$26.1B
| $1.84M | ﹤0.01% |
15,243
+7,818
| +105% | +$880K |
|
1041
Crane NXT
CXT
$2.99B
| $1.84M | ﹤0.01% |
+89,160
| New | +$1.67M |
|
|
EBIX
1042
DELISTED
Ebix Inc
EBIX
| $1.82M | ﹤0.01% |
81,205
+59,086
| +267% | +$1.22M |
|
1043
OGE Energy
OGE
$9.86B
| $1.81M | ﹤0.01% |
59,563
-533,658
| -90% | -$16.5M |
|
|
CNH
1044
CNH Industrial
CNH
$13.4B
| $1.76M | ﹤0.01% |
290,104
-10,503
| -3% | -$58.1K |
|
1045
Regency Centers
REG
$14.9B
| $1.74M | ﹤0.01% |
38,015
+355
| +0.9% | +$15K |
|
1046
New York Times
NYT
$12.6B
| $1.73M | ﹤0.01% |
41,094
+26,002
| +172% | +$946K |
|
|
WORK
1047
DELISTED
Slack Technologies, Inc.
WORK
| $1.72M | ﹤0.01% |
+55,441
| New | +$1.67M |
|
1048
BorgWarner
BWA
$12.8B
| $1.71M | ﹤0.01% |
55,121
-6,591
| -11% | -$174K |
|
|
SYNH
1049
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
| $1.71M | ﹤0.01% |
29,375
+3,932
| +15% | +$211K |
|
1050
NRC Health Common Stock
NRC
$415M
| $1.71M | ﹤0.01% |
29,293
+14,012
| +92% | +$740K |
|
Similar funds
Janus Henderson Group's Q2 2020 Portfolio in Review
As of Q2 2020, Janus Henderson Group held 1,423 positions worth $178B, up 23% from $145B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Janus Henderson Group's Q2 2020 filing shows 132 new, 511 increased, 643 reduced and 125 closed positions. Its largest new stake was Royalty Pharma: 4,507,138 shares worth $219M. The largest sale was Boeing, an estimated $327M.
By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 29% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Janus Henderson Group's largest Q2 2020 buy was Royalty Pharma: 4,507,138 shares worth $219M.
- Janus Henderson Group added most to T-Mobile US in Q2 2020, an estimated $530M increase.
- Janus Henderson Group's biggest Q2 2020 reduction was Boeing, cutting an estimated $327M.
- Janus Henderson Group fully exited Allergan plc in Q2 2020, selling an estimated $128M.
- Janus Henderson Group's ten largest holdings make up 23% of its $178B portfolio in Q2 2020.
- Janus Henderson Group opened 132 new positions and closed 125 in Q2 2020.
- Janus Henderson Group's portfolio value rose 23% quarter-over-quarter to $178B.
Based on Janus Henderson Group's 13F filing for Q2 2020, filed 14 Aug 2020.